Study: Adult Use Marijuana Laws Do Not Adversely Impact Traffic Fatality Rates

The enactment of statewide laws regulating the adult use and sale of cannabis is not associated with subsequent changes in traffic fatality rates, according to an analysis of traffic safety data (“Crash fatality rates after recreational marijuana legalization in Washington and Colorado”) published today in the American Journal of Public Health.

Investigators from the University of Texas-Austin evaluated crash fatality rates in Colorado and Washington pre- and post-legalization. They compared these rates to those of eight control states that had not enacted any significant changes in their marijuana laws.

“We found no significant association between recreational marijuana legalization in Washington and Colorado and subsequent changes in motor vehicle fatality rates in the first three years after recreational marijuana legalization,” author concluded.

Read more at NORML

Study: This Is How Much Marijuana To Use Without Freaking Out

There’s a great ongoing debate in California marijuana circles at the moment—the same ancient question, persistent and pervasive, that’s hovered over legalization since the beginning: How much is too much?

How strong do we allow marijuana edibles to be, before everybody loses their minds?

If you listen to the cannabis industry, edibles packed with 500 milligrams of THC and above are not unreasonable and ought to be a basic sundry good in every dispensary (albeit affixed with warning labels advising the unfamiliar to please, please go slow, and maybe take a few nibbles before swallowing the whole bar and having a well-documented freakout).

Read more at High Times

Study: CBD Administration Reduces Blood Pressure

Oral CBD administration is associated with reduced blood pressure in healthy volunteers, according to clinical trial data published online in the Journal of Clinical Investigation.

Investigators from the University of Nottingham in the United Kingdom assessed the effects of a single oral dose of 600 mg of CBD extract versus placebo in nine male subjects.

Cannabidiol administration reduced resting systolic blood pressure and stroke volume (the amount of blood pumped by the left ventricle of the heart in one contraction). Compared to placebo, CBD intake was associated with reduced BP levels following exercise and in response to stress. Increased heart rate was observed following CBD administration, but no “adverse events” were reported by participants either during or following the study sessions.

Read more at NORML

Touch Drugs, Go to Prison: Cops Use DNA to Bust Alleged Dealer

Last October, police in Milton Keynes, a district just north of London, were searching in the bushes along one of the area’s many bike and pedestrian paths. 

In one bush, they found a package containing 15.82 grams of cocaine and 10.3 grams of heroin.

Two months later, police arrested Darren Levy. Last week, the 35-year old was sentenced to five years in jail for possession with intent to distribute—despite not being anywhere near the drugs in question.

Read more at High Times

Everything You Need to Know About Marijuana Blood Tests

Over the past few years, quite a few states have legalized marijuana for medical and recreational use. With this legalization, police officers needed a way to test drivers who appeared to be too stoned to drive.

This, in turn, has made the marijuana blood test the go-to way to check for impairment during a traffic stop.

Roadside tests and demonstrated impairment still play a role and assessment by a Drug Recognition Expert is now common. But most police departments attempt to verify these results with a blood test. If the allegedly impaired driver has more than the state’s per se limit (often 1 to 5 ng/mL of THC), a DUI conviction usually becomes much more likely.

Read more at High Times

UK to Open First Publicly Available Dedicated Cannabis Research Facility

For a change, let’s hear some good news from the United Kingdom after a month that saw two terrorist attacks and now a tragic apartment fire in London where casualties are mounting as we speak.

The good news is that cannabinoid biotechnology company MediPen Ltd. is launching its own dedicated marijuana research facility this summer, and it will provide a platform for anyone looking to utilize its 1,800 square-foot facilities for the purposes of innovation in the area of medicinal cannabis.

As the first biotechnology company to develop a vapor product, MediPen Ltd. has already enjoyed success selling their non-psychoactive CBD vaporizers, which are currently in the process of securing a license from the British Home Office.

Read more at High Times

New Study Confirms Pot Smokers are Happy, Well Adjusted and Successful

Not to be that person who says “I told you so,” but a new study has concluded that pot smokers are not a bunch of lazy slackers but indeed well-adjusted human beings who cross a large swath of society’s diverse types of individuals.

The landmark new study conducted by BDS Analytics, entitled “Cannabis Consumers are Happy Campers,” surveyed 2,000 California and Colorado adults, with a quota of 1,200 people who have used marijuana within the past six months.

The logic was to gather info from a population sample that was representative of the general public.

Read more at High Times

Does Jeff Sessions Have a Memory Problem? Maybe a Little THC Would Help

Recently we suggested that Attorney General Jeff Sessions might need a little toke to calm himself down before a committee of U.S. senators plied him with questions about Russia meddling in our elections and who was meeting which Russians when, where and why?

Now, it turns out, that the attorney general should have actually heeded our advice but for another reason: to help his failing memory.

Sessions would have done well to read Nature Medicine last month about the German scientists who found that aging mice treated with daily low doses of THC had experienced a reversal of cognitive decline.

Read more at High Times

Scientific American Takes Sessions to Task for Trying to Destroy MMJ Protections

The longest continuously published magazine in the United States has something to say to Attorney General Jeff Sessions: Get with the program.

When Jeff Sessions’ letter to Congress urging it to help him roll back protections shielding medical marijuana was made public this week by Tom Angell of Mass Roots, Scientific American stepped up to the plate.

The 145-year-old authoritative science magazine called out Sessions on his absurd assertions that legal controls protecting MMJ jeopardize the Department of Justice’s (DOJ) ability to combat the country’s “historic drug epidemic” and control dangerous drug traffickers.

Read more at High Times

Study: No Increase In Problematic Cannabis Use Following Passage Of Medical Marijuana Laws

The enactment of medical marijuana laws is not associated with increased rates of problematic cannabis use, according to data published online in the journal Addiction.

Columbia University investigators assessed cannabis use trends in states in the years following the passage of medicalization. They reported “no significant change in the prevalence of past-month marijuana use among adolescents or young adults (those ages 18 to 25)” following legalization. They also found no evidence of increased cannabis abuse or dependence by either young people or adults. States with largely unregulated medical programs were associated with increased self-reported use by adults age 26 and older, but states with stricter programs were not.

The study’s findings are consistent with those of numerous other papers reporting no uptick in youth marijuana use or abuse following medical marijuana regulation, including those here, here, here, here, here, and here. The findings contradict those of a recent, widely publicized paper in JAMA Psychiatry which speculated that medical marijuana laws may increase the prevalence of cannabis use disorder among adults.

Read more at NORML